Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomaras

Showing results (381-390 of 525) with videos related to

Pageof 53
Sort By:
Plos One|May 12, 2017
Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative womenPeter B Gilbert, Jean-Louis Excler, Georgia D Tomaras, et al.
AIDS Research and Human Retroviruses|April 23, 2019
HIV Research for Prevention 2018: From Research to Impact Conference Summary and HighlightsBarbara L Shacklett, Julià Blanco, Lisa Hightow-Weidman, et al.
Iscience|July 1, 2026
<i>In vitro</i> recapitulation of intramuscular mRNA vaccination with naive and recall antigens using a human lymphoid follicle chip platformYunhao Zhai, Min Wen Ku, Ka Yang, et al.
Science Immunology|June 21, 2020
3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primatesSudhir Pai Kasturi, Mohammed Ata Ur Rasheed, Colin Havenar-Daughton, et al.
JCI Insight|May 22, 2020
Robust antibody and cellular responses induced by DNA-only vaccination for HIVStephen C De Rosa, Srilatha Edupuganti, Yunda Huang, et al.
The Journal of Infectious Diseases|November 9, 2022
Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a StudyDaniel J Stieh, Dan H Barouch, Christy Comeaux, et al.
Plos One|January 26, 2013
Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trialSusan Zolla-Pazner, Allan C deCamp, Timothy Cardozo, et al.
Nature Biomedical Engineering|March 12, 2026
DNA origami vaccine nanoparticles improve humoral and cellular immune responses to infectious diseasesYang C Zeng, Olivia J Young, Qiancheng Xiong, et al.
Ebiomedicine|December 7, 2016
Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated ProtectionRena D Astronomo, Sampa Santra, Lamar Ballweber-Fleming, et al.
Journal of Virology|November 16, 2018
Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVACKaren V Kibler, Benedikt Asbach, Beatriz Perdiguero, et al.
Pageof 53

Showing results (381-390 of 525) with videos related to

Sort By:
Pageof 53
Plos One|May 12, 2017
Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative womenPeter B Gilbert, Jean-Louis Excler, Georgia D Tomaras, et al.
AIDS Research and Human Retroviruses|April 23, 2019
HIV Research for Prevention 2018: From Research to Impact Conference Summary and HighlightsBarbara L Shacklett, Julià Blanco, Lisa Hightow-Weidman, et al.
Iscience|July 1, 2026
<i>In vitro</i> recapitulation of intramuscular mRNA vaccination with naive and recall antigens using a human lymphoid follicle chip platformYunhao Zhai, Min Wen Ku, Ka Yang, et al.
Science Immunology|June 21, 2020
3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primatesSudhir Pai Kasturi, Mohammed Ata Ur Rasheed, Colin Havenar-Daughton, et al.
JCI Insight|May 22, 2020
Robust antibody and cellular responses induced by DNA-only vaccination for HIVStephen C De Rosa, Srilatha Edupuganti, Yunda Huang, et al.
The Journal of Infectious Diseases|November 9, 2022
Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a StudyDaniel J Stieh, Dan H Barouch, Christy Comeaux, et al.
Plos One|January 26, 2013
Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trialSusan Zolla-Pazner, Allan C deCamp, Timothy Cardozo, et al.
Nature Biomedical Engineering|March 12, 2026
DNA origami vaccine nanoparticles improve humoral and cellular immune responses to infectious diseasesYang C Zeng, Olivia J Young, Qiancheng Xiong, et al.
Ebiomedicine|December 7, 2016
Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated ProtectionRena D Astronomo, Sampa Santra, Lamar Ballweber-Fleming, et al.
Journal of Virology|November 16, 2018
Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVACKaren V Kibler, Benedikt Asbach, Beatriz Perdiguero, et al.
Pageof 53